ACHV

Achieve Life Sciences, Inc.

4.26

USD

ACHV Earnings Reports

Positive Surprise Ratio

ACHV beat 18 of 33 last estimates.

55%

Next Report

Date of Next Report

Mar 09, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.27

Implied change from Q3 25 (Revenue/ EPS)

-3.57%

Implied change from Q4 24 (Revenue/ EPS)

-25.00%

Achieve Life Sciences, Inc. earnings per share and revenue

On Nov 06, 2025, ACHV reported earnings of -0.28 USD per share (EPS) for Q3 25, missing the estimate of -0.26 USD, resulting in a -6.75% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.85% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 9 analysts forecast an EPS of -0.27 USD, with revenue projected to reach -- USD, implying an decrease of -3.57% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Takeda Pharmaceutical Company Limited - ADR

Report Date

Jan 30, 2026 For Q3 26

Estimate

$34.44

Actual

$65.64

Surprise

+90.61%

FAQ

What were Achieve Life Sciences, Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Achieve Life Sciences, Inc. reported EPS of -$0.28, missing estimates by -6.75%, and revenue of $0.00, 0% as expectations.

How did the market react to Achieve Life Sciences, Inc.'s Q3 2025 earnings?

The stock price moved down -3.85%, changed from $4.93 before the earnings release to $4.74 the day after.

When is Achieve Life Sciences, Inc. expected to report next?

The next earning report is scheduled for Mar 09, 2026.

What are the forecasts for Achieve Life Sciences, Inc.'s next earnings report?

Based on 9 analysts, Achieve Life Sciences, Inc. is expected to report EPS of -$0.27 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.